Cargando…
Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions
Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which the lungs become irreversibly scarred, leading to declining lung function. As currently available drugs do not cure IPF, there remains a great medical need for more effective treatments. Perhaps this need could be addressed by gene th...
Autores principales: | Ruigrok, Mitchel J.R., Frijlink, Henderik W., Melgert, Barbro N., Olinga, Peter, Hinrichs, Wouter L.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868939/ https://www.ncbi.nlm.nih.gov/pubmed/33614824 http://dx.doi.org/10.1016/j.omtm.2021.01.003 |
Ejemplares similares
-
The effects of oxygen concentration on cell death, anti-oxidant transcription, acute inflammation, and cell proliferation in precision-cut lung slices
por: Ruigrok, Mitchel J. R., et al.
Publicado: (2019) -
Silencing Heat Shock Protein 47 (HSP47) in Fibrogenic Precision-Cut Lung Slices: A Surprising Lack of Effects on Fibrogenesis?
por: Ruigrok, Mitchel J. R., et al.
Publicado: (2021) -
RANKL confers protection against cell death in precision-cut lung slices
por: Ruigrok, M. J. R., et al.
Publicado: (2022) -
Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration
por: Heida, Rick, et al.
Publicado: (2023) -
Bottom-Up Preparation Techniques for Nanocrystals of Lipophilic Drugs
por: de Waard, Hans, et al.
Publicado: (2010)